SCHEMBL6770531

SCHEMBL6770531

CC(C)c1ccc(-n2nc(-c3ccccc3)c3c2CC(C)(C)C(C#N)C3=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
LMNA P02545 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
HTT P42858 1/20 0.40
DHODH Q02127 1/20 0.35
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2D6 P10635 1/20 0.34
OPRM1 P35372 2/20 0.34
PTGS2 P35354 3/20 0.33
PTGS1 P23219 2/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
CCNA2 P20248 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771211 0.91 MEN1 (0.34) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6770382 0.89 MEN1 (0.34) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6766535 0.88 DHODH (0.36) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6777360 0.87 OPRM1 (0.39) MEN1KMT2ALMNAHTTDHODH
SCHEMBL6770141 0.87 PTGS1 (0.41) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6767179 0.86 POLB (0.35) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6769818 0.86 OPRM1 (0.34) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6772430 0.85 CCNA2 (0.44) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6770744 0.85 CYP2C9 (0.38) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL6771166 0.85 OPRM1 (0.32) MEN1KMT2ALMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed